Research analysts at StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Tonix Pharmaceuticals (NASDAQ: TNXP) released selected preliminary financial results for 2024, reporting approximately $98.8 million in cash and cas ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Tonix Pharmaceuticals (TNXP) stock jumped 11% Friday after the company issued a business update along with a preliminary 2024 ...

Tonix shares are moving higher on Friday after the company provided preliminary 2024 fiscal-year financial results.

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities ...

The Company had approximately $98.8 million in cash and cash equivalents as of December 31, 2024. Maximize Your Portfolio with Data Driven ...

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first ...